Ultralife (ULBI) Projected to Post Earnings on Tuesday

Ultralife (NASDAQ:ULBI - Get Free Report) is expected to announce its Q4 earnings results before the market opens on Tuesday, April 1st. Analysts expect the company to announce earnings of $0.15 per share and revenue of $40.00 million for the quarter. Individual that are interested in registering for the company's earnings conference call can do so using this link.

Ultralife (NASDAQ:ULBI - Get Free Report) last posted its quarterly earnings results on Tuesday, April 1st. The technology company reported $0.01 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.14). The company had revenue of $43.85 million for the quarter, compared to analyst estimates of $40.00 million. Ultralife had a net margin of 5.44% and a return on equity of 7.92%. During the same quarter in the previous year, the business posted $0.18 earnings per share.

Ultralife Price Performance

Shares of ULBI traded down $0.31 on Tuesday, reaching $5.07. The stock had a trading volume of 128,791 shares, compared to its average volume of 75,145. Ultralife has a twelve month low of $4.43 and a twelve month high of $13.39. The firm has a market capitalization of $84.30 million, a PE ratio of 9.21 and a beta of 1.05. The firm has a 50-day moving average of $6.62 and a 200 day moving average of $7.68. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04.

Institutional Investors Weigh In On Ultralife

A hedge fund recently raised its stake in Ultralife stock. Bank of America Corp DE increased its position in Ultralife Co. (NASDAQ:ULBI - Free Report) by 30.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,067 shares of the technology company's stock after buying an additional 2,836 shares during the quarter. Bank of America Corp DE owned about 0.07% of Ultralife worth $90,000 as of its most recent filing with the Securities and Exchange Commission. 30.68% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com cut Ultralife from a "buy" rating to a "hold" rating in a research report on Tuesday, March 18th.

Ultralife Company Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.